Syndax: 3Q Earnings Snapshot

November 5, 2018

WALTHAM, Mass. (AP) _ Syndax Pharmaceuticals Inc. (SNDX) on Monday reported a loss of $17.3 million in its third quarter.

On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 68 cents.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.

The biopharmaceutical company posted revenue of $379,000 in the period.

In the final minutes of trading on Monday, the company’s shares hit $4.86. A year ago, they were trading at $11.45.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX